Stockscreener 앱 받기
31.88
4.15%
-1.38
시간 외 거래:
33.47
1.59
+4.99%
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Bank of New York Mellon Corp Has $3.33 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Buy" by Analysts - MarketBeat
TD Asset Management Inc Sells 13,200 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Analysts - Defense World
Prepare Yourself for Liftoff: Tarsus Pharmaceuticals Inc (TARS) - SETE News
Insider Selling: LINK WILLIAM J PHD, Tarsus Pharmaceuticals Inc [TARS] Director divested 35,000 shares - Knox Daily
Midday Stock Roundup: LoanDepot Inc. Back in Positive Territory - Orange County Business Journal
Questex’s Fierce Pharma Announces the 2024 Fierce Pharma Marketing Awards Winners - GlobeNewswire Inc.
Financial Metrics Check: Tarsus Pharmaceuticals Inc (TARS)’s Ratios for Trailing Twelve Months - The Dwinnex
What technical indicators reveal about TARS stock - US Post News
Zurcher Kantonalbank Zurich Cantonalbank Has $166,000 Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Bought by Cowen AND Company LLC - MarketBeat
Tarsus Pharmaceuticals’ Xdemvy demonstrates positive efficacy and safety in treatment for patients with Demodex blepharitis. - 2 Minute Medicine
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up to $27.31 - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up to $27.31 - MarketBeat
Tarsus Pharmaceuticals Inc (TARS) Is Worth A Look Now, Despite -29.44% Loss From High - Stocks Register
It is Poised to be a Bull Market for Tarsus Pharmaceuticals Inc (TARS) - SETE News
Financial Metrics Exploration: Understanding Tarsus Pharmaceuticals Inc (TARS) Through Ratios - The Dwinnex
Tarsus Pharmaceuticals Inc [TARS] Shares Rise 10.93 % on Wednesday - Knox Daily
The Psychology of Tarsus Pharmaceuticals Inc Inc. (TARS) Price Performance: Understanding Market Sentiment - The InvestChronicle
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable - Simply Wall St
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 5.1% - MarketBeat
Tarsus Pharmaceuticals Inc (TARS) shows promising results - US Post News
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Tarsus Pharmaceuticals Inc [TARS] Records 50-Day SMA of $26.40 - Knox Daily
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference - GlobeNewswire
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference - StockTitan
SG Americas Securities LLC Cuts Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Long Term Trading Analysis for (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 4.7% Higher - MarketBeat
Check Out Tarsus Pharmaceuticals Inc (TARS)’s Trade Data Rather Than the Analysts’ Views - SETE News
Director, LINK WILLIAM J PHD sold 35,000 shares of Tarsus Pharmaceuticals Inc [TARS] - Knox Daily
Tarsus Pharmaceuticals Inc [TARS] Shares Jump Approximately 52.34% Over the Year - Knox Daily
The growth track for Tarsus Pharmaceuticals Inc (TARS) has changed recently - SETE News
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $51.17 Average PT from Brokerages - MarketBeat
Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals Inc (TARS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Tarsus Sees 65% Jump in Sales to $40.8M - Orange County Business Journal
Analyzing Ratios: Tarsus Pharmaceuticals Inc (TARS)’s Financial Story Unveiled - The Dwinnex
This Insider Has Just Sold Shares In Tarsus Pharmaceuticals - Simply Wall St
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 3.7% - Defense World
Assenagon Asset Management S.A. Makes New Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 3.7% - MarketBeat
Tarsus Pharmaceuticals Inc [TARS] Director makes an insider sale of 35,000 shares worth 912,961. - Knox Daily
Tarsus Pharmaceuticals director sells over $900k in company stock By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals director sells over $900k in company stock - Investing.com India
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by California State Teachers Retirement System - Defense World
Tarsus Pharmaceuticals director sells over $900k in company stock - Investing.com
Tarsus Pharmaceuticals director sells over $900k in company stock By Investing.com - Investing.com UK
Tarsus Pharmaceuticals Inc (TARS) can make a big difference with a little luck - SETE News
Market Momentum: Tarsus Pharmaceuticals Inc (TARS) Registers a 0.88 Increase, Closing at 26.44 - The Dwinnex
Tarsus Pharmaceuticals director sells over $900k in company stock By Investing.com - Investing.com Canada
Small But Mitey: Tarsus To Amp Up Strong Xdemvy Launch - Scrip
A closer look at Tarsus Pharmaceuticals Inc (TARS)’s stock price trends - US Post News
Tarsus Pharmaceuticals Inc [TARS] stock was sold by Farrow Jeffrey S at the price of US$0.29 million - Knox Daily
Tarsus Pharmaceuticals Inc (TARS Stock: A Sea of Opportunity - The InvestChronicle
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q2 2024 Earnings Call Transcript - Insider Monkey
Oppenheimer Reaffirms “Outperform” Rating for Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals Reports 65 Percent Growth in Second Quarter; Shares Year-to-Date Financial Results - Vision Monday
Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues - Yahoo Finance
1.10%
1.27%
자본화:
|
볼륨(24시간):